Skip to content

Clinical trials

Phase 2 Lymphoma, Large-Cell, Anaplastic trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Large-Cell, Anaplastic Phase: Phase 2 Clear all

107 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20007
20013
20021
20035
20049
200512
20065
20076
20082
20096
20105
20115
20125
20132
20141
20154
20165
20173
20183
20193
20212
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed69
Terminated19
Unknown status6
Withdrawn6
Active, not recruiting4
Recruiting2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)16
Fred Hutchinson Cancer Center13
City of Hope Medical Center4
Mayo Clinic4
Memorial Sloan Kettering Cancer Center4
Seagen Inc.4
Case Comprehensive Cancer Center3
Eastern Cooperative Oncology Group3
European Organisation for Research and Treatment of Cancer - EORTC3
Northside Hospital, Inc.3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Large-Cell, Anaplastic107
Lymphoma, Large B-Cell, Diffuse67
Lymphoma, Follicular54
Lymphoma, Mantle-Cell54
Lymphoma, Non-Hodgkin53
Burkitt Lymphoma51
Lymphoma, Large-Cell, Immunoblastic49
Lymphoma48
Hodgkin Disease47
Immunoblastic Lymphadenopathy46

Trials

Showing 51 to 75 of 107. Each trial links to its page on Pharma Observatory.

7 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.